New drug tested to halt teen vision loss from rare eye disease
Disease control
Completed
This study tested whether a drug called tinlarebant could slow the progression of Stargardt disease, a rare genetic condition that causes vision loss in young people. About 104 teenagers and young adults took either the drug or a placebo for up to two years. The main goal was to …
Phase: PHASE3 • Sponsor: Belite Bio, Inc • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC